CYCS and osteosarcoma: In addition, the binding of CypD and Bcl-2 enhances the limiting effect of Bcl-2 on cytochrome C (Cyto C) release and improves the antiapoptotic effect of various tumor cell lines (human osteosarcoma cell line Saos2 and human acute leukemia cell line HL60) (55).